Overall rank by patents
#340
of 49,997 tracked assignees
USPTO PatentsView assignee record - 1,265 granted patents across 51 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device).
The verdict
According to USPTO PatentsView, Edwards ranks #340 of 49,997 tracked US assignees by granted-patent volume, with 1,265 patents across 51 technology areas.
USPTO PatentsView assignee plate
Corpus R340 · US Corporation #340 · 1,265 grants
GRANTS-LARGE · TOP-DECILE · PHOTO-FINISH · CPC-WIDE · INNOV-STRONG · CLAIMS-RICH · TYPE-USCORP · VEL-SURGE · BOOK-FULL
Nearest grant-volume peer: The Trustees of the University of Pennsylvania (±1 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
Qualcomm Incorporated · highest
85 score
Mediatek · near
67 score
Polytec · near
67 score
Edwards Lifesciences · this assignee
67 score
The Board of… · near
67 score
Viasat · near
67 score
3D Lighting… · lowest
7 score
What this shows Edwards's Innovation Score is 67.2/100 (top 1% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Between 2020–2024, Edwards Lifesciences Corporation received 732 grants versus 401 in 2015–2019 (+83% equal-window velocity, above median growth). Across complete PatentsView years, output peaked in 2024 at 172 grants and bottomed in 2015 at 49. Lead class A61F accounts for 87% of the portfolio across 51 subclasses. Volume neighbours: Google Technology Holdings LLC (#336) and Merck Sharp & Dohme LLC (#344).
From 2019–2021 to 2022–2024, Edwards Lifesciences Corporation moved from 444 to 422 grants (0.95x the prior three-year total, a multiple, not a CAGR). Among 3,296 tracked assignees with ≥100 grants and ≥20 prior-period grants, that multiple ranks #1,318. See the growth leaderboard.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
Google Technology Holdings LLC
1,294 patents
Makita Corporation
1,292 patents
Nippon Steel Corporation
1,289 patents
SZ DJI Technology Co., Ltd.
1,268 patents
Edwards Lifesciences Corporation
1,265 patents
The Trustees of the University of Pennsylvania
1,264 patents
Terumo Kabushiki Kaisha
1,250 patents
Empire Technology Development LLC
1,248 patents
Merck Sharp & Dohme LLC
1,248 patents
What this shows Edwards holds 1,265 patents at rank #340, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #340 in granted patent volume.
Other assignees with the most granted patents in Edwards's primary technology class.
Two PlainPatent-derived peer sets for Edwards, neither rank-band nor same-CPC leaders (those blocks stay above).
Nearest assignees by Innovation Score (67 here).
Nearest assignees by average claims per patent (18.6 here).
Edwards's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
67 Top 1% higher than 99% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 49 | 3.9% |
| 2016 | 66 | 5.2% |
| 2017 | 61 | 4.8% |
| 2018 | 91 | 7.2% |
| 2019 | 134 | 10.6% |
| 2020 | 153 | 12.1% |
| 2021 | 157 | 12.4% |
| 2022 | 112 | 8.9% |
| 2023 | 138 | 10.9% |
| 2024 | 172 | 13.6% |
| 2025partial year | 132 | 10.4% |
Top 15 of 51 technology areas
Overall rank by patents
#340
of 49,997 tracked assignees
67.2 out of 100
What to do with this data
Edwards Lifesciences Corporation's patent record in context - here's where to go next.
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.